Arkolith/Insider Trading/TFFP/Form 4

Weisman Harlan F

President and CEO, DirectorTFF Pharmaceuticals, Inc. (TFFP) · full profile →Form 4 · filed Mar 13, 2023
Net Buying
Open-Market Buys
$132K
Open-Market Sells
$0
Net Open-Market Flow
$132K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2023Buy(P)150K$0.88$132K215K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-23-019384) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML